CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)
Clinical trial NCT06752876 · WITHDRAWN
Trial details
- NCT number
- NCT06752876
- Sponsor
- Caribou Biosciences, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-12-01
- Primary completion
- 2029-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.